| Literature DB >> 30984701 |
Mohammad R Hafezi Ahmadi1,2, Zeinab Bakhtari3, Behrang Kazeminezhad4, Samiramis Ghavam5.
Abstract
INTRODUCTION: Skin cancer, the melanoma type of which causes high mortality, is the most common malignancy in Iran and all over the world. UV is the most important cause of the incidence of this disease. This study evaluates the frequency of different types of cancer and their trajectory in Ilam province from 2012 to 2011.Entities:
Keywords: Basal cell carcinoma; Ilam; skin cancer; squamous cell carcinoma
Year: 2019 PMID: 30984701 PMCID: PMC6436317 DOI: 10.4103/jfmpc.jfmpc_178_17
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Figure 1Age frequency distribution of skin cancer patients in Ilam during 2002 to 2011
The frequency distribution of clinical forms of cutaneous malignant tumors in terms of some variables
| Total | Other tumors | Metastatic | Melanoma | SCC | BCC | Tumor type Variables | |
|---|---|---|---|---|---|---|---|
| 227 (%100) | 9 (%3/96) | 4 (%1/76) | 9 (%3/96) | 49 (%21/58) | 156 (%68/72) | Men | Sex |
| 120 (%100) | 11 (%9/16) | 4 (%3/33) | 7 (%5/83) | 14 (%11/66) | 84 (%70) | Women | |
| 347 (%100) | 20 (%5/76) | 8 (%2/30) | 16 (%4/61) | 63 (%18/15) | 240 (69/16%) | Total | |
| 63/90±14/88 | 40.44±18/09 | 67/75±9/21 | 57/88±16/87 | 67/87±14/98 | 64/25±13/44 | Men | Age (mean±SD) |
| 59/60±17/95 | 56/63±22/47 | 52/00±20/47 | 64/00±22/75 | 62/85±21/31 | 59/45±16/44 | Women | |
| 62/41±16/11 | 49/35±21/72 | 59/87±16/94 | 60/56±19/20 | 66/76±16/53 | 62/57±14/70 | Total | |
| 283 (%100/0) | 8 (%2/8) | 4 (%1/4) | 8 (%2/8) | 47 (%16/6) | 216(%76/3) | Face | Location of incidence |
| 14 (%100/0) | 0 (%0/0) | 0 (%0/0) | 1 (%7/1) | 5 (%35/7) | 8 (%57/1) | Neck | |
| 26 (%100/0) | 7 (%26/9) | 3 (%11/5) | 2 (%7/7) | 5 (%19/2) | 9 (%34/6) | Body | |
| 6 (%100/0) | 1 (%16/7) | 0 (%0/0) | 0 (%0/0) | 2 (%33/3) | 3 (%50/0) | Hand | |
| 18 (%100/0) | 4 (%22/2) | 1 (%5/6) | 5 (%27/8) | 4 (%22/2) | 4 (%22/2) | Foot | |
| 221 (%100/0) | 13 (%5/9) | 6 (%2/7) | 11 (%5/0) | 35 (%15/8) | 156 (%70/6) | Urban | Place |
| 126 (%100/0) | 7 (%5/6) | 2 (%1/6) | 5 (%4/0) | 28 (%22/2) | 84 (%66/7) | Rural | |
BCC: Basal cell carcinoma; SCC: Squamous cell carcinoma
The frequency distribution of clinical forms of cutaneous malignant tumors in terms of age groups
| Total | Other tumors | Metastatic | Melanoma | SCC | BCC | Tumor type Age | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Percent | Frequency | Percent | Frequency | Percent | Frequency | Percent | Frequency | Percent | Frequency | Percent | Frequency | |
| 1/7 | 6 | 50 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 50 | 3 | 1-19 |
| 6/9 | 24 | 12/5 | 3 | 4/2 | 1 | 12/5 | 3 | 16/7 | 4 | 54/2 | 13 | 20-39 |
| 31/7 | 110 | 6/4 | 7 | 0/9 | 1 | 4/5 | 5 | 12/7 | 14 | 75/5 | 83 | 40-59 |
| 45 | 156 | 3/2 | 5 | 0/6 | 1 | 3/8 | 6 | 17/9 | 28 | 74/4 | 116 | 60-79 |
| 14/7 | 51 | 3/9 | 2 | 0 | 0 | 3/9 | 2 | 33/3 | 17 | 58/8 | 30 | >80 |
BCC: Basal cell carcinoma; SCC: Squamous cell carcinoma
Figure 2Sex-based growth of malignant cutaneous tumors during 2002 to 2011
Frequency distribution of miscellaneous skin cancers
| Name of the tumor | Frequency |
|---|---|
| Malignant fibrous histiocytoma | 1 |
| Sarcoma, NOS | 2 |
| Dermatofibrosarcoma protuberans | 3 |
| Kaposi sarcoma | 3 |
| Leiomysarcoma | 2 |
| Bowen’s disease | 5 |
| T-cell lymphoma | 1 |
| Malignant lymphoma | 1 |
| Fibrosarcoma | 1 |
| Basosquamous cell carcinoma | 1 |
| Total | 20 |
Frequency distribution of cutaneous malignant tumors in terms of the year of incidence
| Total | Other tumors | Metastatic | Melanoma | SCC | BCC | Tumor type Age | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Percent | Frequency | Percent | Frequency | Percent | Frequency | Percent | Frequency | Percent | Frequency | Percent | Frequency | |
| 100/0 | 13731 | 0/0 | 0 | 9/1 | 1 | 0/0 | 0 | 0/0 | 0 | 9/9 | 10 | 2002 |
| 100/0 | 14 | 0/0 | 0 | 7/1 | 1 | 0 | 14/3 | 0/0 | 2 | 78/6 | 11 | 2003 |
| 100/0 | 16 | 6/2 | 6/2 | 1 | 1 | 12/5 | 25/0 | 2 | 4 | 50/0 | 8 | 2004 |
| 100/0 | 26 | 15/4 | 4 | 3/8 | 1 | 3/8 | 1 | 26/9 | 7 | 50/0 | 13 | 2005 |
| 100/0 | 40 | 2/5 | 1 | 5/0 | 7/5 | 2 | 3 | 7 | 67/5 | 17/5 | 27 | 2006 |
| 100/0 | 45 | 2/2 | 1 | 4/4 | 2 | 6/7 | 3 | 11/1 | 5 | 75/6 | 34 | 2007 |
| 100/0 | 50 | 6/0 | 3 | 0/0 | 0 | 4/0 | 2 | 24/0 | 12 | 66/0 | 33 | 2008 |
| 100/0 | 52 | 7/7 | 4 | 0 | 0/0 | 0/0 | 0 | 21/2 | 11 | 71/2 | 37 | 2009 |
| 100/0 | 48 | 6/2 | 3 | 0/0 | 0 | 2/1 | 1 | 16/7 | 8 | 75/0 | 36 | 2010 |
| 100/0 | 45 | 6/7 | 3 | 0/0 | 0 | 8/9 | 4 | 15/6 | 7 | 68/9 | 31 | 2011 |
| 100/0 | 347 | 5/8 | 20 | 2/3 | 8 | 4/6 | 16 | 18/2 | 63 | 69/2 | 240 | Total |
BCC: Basal cell carcinoma; SCC: Squamous cell carcinoma